Cyclopharm Ltd has released a press release.
Confirmation of Technegas USFDA Timetable
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cyclopharm
- Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020
- Cyclopharm Successfully Completes A$30 Million Placement
- SNMMI Requests USFDA to Expedite Approval For Technegas
- USFDA Approval Progress for Technegas and Business Update
- Cyclopharm Investor Presentation
Later from Cyclopharm
- S&P DJI Announces March 2021 Quarterly Rebalance
- Chairmans Address to Shareholders
- CYC 2021 AGM Presentation
- Managing Directors Address to Shareholders
- CYC First Half Trading Update
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm